Empowering data-driven decisions in drug discovery
In the modern drug discovery process and in an investment-centered climate, de-risking development journeys is a major challenge. Paul Vauterin at BioLizard explains how tailored analytics can assist in safely speeding up the drug discovery and development process....
Biomarker discovery 2.0: Using new technologies to access novel insights into human health and disease
Due to the size and dimensionality of the datasets required, data science is an essential component of modern biomarker discovery and development. It’s no longer feasible to mine and process these data sets manually, which demands collaboration between R&D...
Beyond diagnostics: How biomarkers can be used to de-risk drug development
Biomarker discovery is important not only in the pursuit of better diagnostics but also for de-risking drug development. By leveraging validated biomarkers, you can prioritize drug candidates with higher likelihoods of therapeutic success, thereby reducing the risk of...